Petra Dieterich
Senior Vice President & Scientific Leader Abzena
Petra holds the position of Senior Vice President & Scientific Leader at Abzena. Petra has 30 years of experience in drug development in the Pharmaceutical industry with a focus on supporting CMC activities, R&D, Chemistry, and Bioconjugation.
Seminars
Tuesday 24th February 2026
Leveraging Bioconjugation Strategies to Enhance AOC CMC Processes
12:30 pm
- Navigating the nuances of AOC process development and understanding how to leverage physiochemical properties and chemistry aspects between different AOCs
- Comparing AOCs with classical ADCs across payload complexity, impurity profiles, and essential analytical methods
- Assessing the evolving regulatory framework, impurity control, stability, immunogenicity and target product profiles
- Spotlighting real-world customer case studies that demonstrate a risk-managed approach to get to the clinic quicker
